PRCT

SEC source: 0001628280-26-016153 · wk-form4_1773092610.xml · derivative · entry 3

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,615

Underlying: Common Stock · 29,615 shares

Expires 2036-03-04

F3 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.

SEC source: 0001628280-26-016153 · wk-form4_1773092610.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,156

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2027, with onesixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date.

SEC source: 0001628280-26-016151 · wk-form4_1773092446.xml · derivative · entry 3

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,576

Underlying: Common Stock · 32,576 shares

Expires 2036-03-04

F3 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.

SEC source: 0001628280-26-016151 · wk-form4_1773092446.xml · nonDerivative · entry 1

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,985

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2027, with onesixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date.

SEC source: 0001628280-26-016149 · wk-form4_1773092380.xml · derivative · entry 2

PUCKETT DAN · CIK 0001602773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,897

Underlying: Common Stock · 8,897 shares

Expires 2036-03-04

F2 · derivative.exercise_date: This Stock Option was granted on March 5, 2026, and one-third of the shares subject to the Stock Option shall vest on March 5, 2027, with one-third of the remaining shares subject to the Stock Option vesting annually on each of the second and third anniversary thereof, subject to the Reporting Person continuing as a service provider through such date.

SEC source: 0001628280-26-016149 · wk-form4_1773092380.xml · nonDerivative · entry 1

PUCKETT DAN · CIK 0001602773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,476

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-third of the RSUs shall vest on March 5, 2027, with one-third of the remaining RSUs vesting annually on each of the second and third anniversary thereof, subject to the Reporting Person continuing as a service provider through such date.

SEC source: 0001628280-26-011747 · wk-form4_1772056048.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,345

F1 · shares: Represents shares of common stock underlying a portion of an award of performance stock units ("PSUs") previously granted by the Issuer, the vesting of which was subject to the Issuer's achievement of certain pre-determined performance criteria. Upon certification by the Issuer's Compensation Committee on February 19, 2026, of the achievement of such performance criteria, the number of PSUs reported herein was deemed earned, which will vest on March 5, 2026. Each PSU represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001628280-26-011744 · wk-form4_1772056009.xml · nonDerivative · entry 1

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,523

F1 · kind: Represents shares of common stock underlying a portion of an award of performance stock units ("PSUs") previously granted by the Issuer, the vesting of which was subject to the Issuer's achievement of certain pre-determined performance criteria. Upon certification by the Issuer's Compensation Committee on February 19, 2026, of the achievement of such performance criteria, the number of PSUs reported herein was deemed earned, which will vest on March 5, 2026. Each PSU represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001440660-25-000004 · wk-form4_1757021993.xml · derivative · entry 2

Wood Larry L · CIK 0001440660 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 319,618

Underlying: Common Stock · 319,618 shares

Expires 2036-09-01

F3 · derivative.exercise_date: The Stock Option was granted on September 2, 2025 and one-quarter of the shares subject to the Stock Option will vest on September 2, 2026, and the remainder shall vest monthly thereafter at the rate of 1/48th of the original number of shares subject to the Stock Option, subject to the Reporting Person continuing as a service provider through such date.

SEC source: 0001440660-25-000004 · wk-form4_1757021993.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,595

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on September 2, 2026, with one-twelfth of the remaining RSUs shall vest on each quarter thereafter, subject to the Reporting Person continuing as a service provider through such date.

F2 · balance_after: The ending balance was adjusted to reflect the forfeiture (for no consideration) of 2,765 unvested RSUs previously granted to the Reporting Person in April 2024 and June 2025 under the issuer's non-employee director compensation program.

SEC source: 0001628280-25-040389 · wk-form4_1755202552.xml · derivative · entry 2

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,452

Underlying: Common Stock · 11,000 shares

Expires 2028-09-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction is a cash exercise by the reporting person.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001628280-25-040389 · wk-form4_1755202552.xml · nonDerivative · entry 1

Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,473

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-25-040568 · wk-form4_1755291190.xml · derivative · entry 3

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 26,749 shares

Expires 2025-09-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction is a cash exercise by the reporting person.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001628280-25-040568 · wk-form4_1755291190.xml · nonDerivative · entry 1

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,152

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-25-040397 · wk-form4_1755202701.xml · nonDerivative · entry 1

MOLL FREDERIC H · CIK 0001260157 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 863,159

F1 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $38.71 to $39.645, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-031117 · wk-form4_1749770906.xml · nonDerivative · entry 9

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 14,363

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on Novemer 5, 2024.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.89 to $62.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-031117 · wk-form4_1749770906.xml · nonDerivative · entry 8

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 19,412

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on Novemer 5, 2024.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.89 to $61.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-031117 · wk-form4_1749770906.xml · nonDerivative · entry 7

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 39,363

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on Novemer 5, 2024.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.08 to $64.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-031117 · wk-form4_1749770906.xml · nonDerivative · entry 6

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 45,080

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on Novemer 5, 2024.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.08 to $64.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-031117 · wk-form4_1749770906.xml · nonDerivative · entry 5

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 56,575

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on Novemer 5, 2024.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.08 to $63.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-031117 · wk-form4_1749770906.xml · derivative · entry 10

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,771

Underlying: Common Stock · 2,771 shares

Expires 2035-06-09

F11 · derivative.exercise_date: The Stock Option was granted on June 10, 2025 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001628280-25-031117 · wk-form4_1749770906.xml · nonDerivative · entry 4

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,403

F5 · kind: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001628280-25-031117 · wk-form4_1749770906.xml · nonDerivative · entry 3

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 64,363

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on Novemer 5, 2024.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.56 to $64.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-031117 · wk-form4_1749770906.xml · nonDerivative · entry 2

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 66,089

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on Novemer 5, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.56 to $64.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-031117 · wk-form4_1749770906.xml · nonDerivative · entry 1

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 84,501

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on Novemer 5, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.56 to $63.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-030987 · wk-form4_1749759946.xml · derivative · entry 2

Wood Larry L · CIK 0001440660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,771

Underlying: Common Stock · 2,771 shares

Expires 2035-06-09

F2 · derivative.exercise_date: The Stock option was granted on June 10, 2025 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001628280-25-030987 · wk-form4_1749759946.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,968

F1 · kind: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001628280-25-030996 · wk-form4_1749760050.xml · derivative · entry 2

MOLL FREDERIC H · CIK 0001260157 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,771

Underlying: Common Stock · 2,771 shares

Expires 2035-06-09

F2 · derivative.exercise_date: The Stock option was granted on June 10, 2025 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001628280-25-030996 · wk-form4_1749760050.xml · nonDerivative · entry 1

MOLL FREDERIC H · CIK 0001260157 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 843,159

F1 · kind: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001628280-25-030956 · wk-form4_1749759306.xml · derivative · entry 2

PRESCOTT THOMAS M · CIK 0001234773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,771

Underlying: Common Stock · 2,771 shares

Expires 2035-06-09

F2 · derivative.exercise_date: The Stock option was granted on June 10, 2025 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001628280-25-030956 · wk-form4_1749759306.xml · nonDerivative · entry 1

PRESCOTT THOMAS M · CIK 0001234773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,896

F1 · kind: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001628280-25-030982 · wk-form4_1749759897.xml · derivative · entry 3

Harris Taylor C. · CIK 0001560168 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,771

Underlying: Common Stock · 2,771 shares

Expires 2035-06-09

F3 · derivative.exercise_date: The Stock option was granted on June 10, 2025 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001628280-25-030982 · wk-form4_1749759897.xml · nonDerivative · entry 1

Harris Taylor C. · CIK 0001560168 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,176

F1 · kind: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

F2 · balance_after: Reported share balance adjusted to reflect the ownerhsip of 35,074 shares held in the name of The Harris Trust, of which Taylor Harris the the trustee.

SEC source: 0001628280-25-030992 · wk-form4_1749759999.xml · derivative · entry 2

Sandoval Elisabeth · CIK 0001632295 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,771

Underlying: Common Stock · 2,771 shares

Expires 2035-06-09

F2 · derivative.exercise_date: The Stock option was granted on June 10, 2025 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001628280-25-030992 · wk-form4_1749759999.xml · nonDerivative · entry 1

Sandoval Elisabeth · CIK 0001632295 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,561

F1 · kind: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001628280-25-030979 · wk-form4_1749759842.xml · derivative · entry 2

Garrett Mary · CIK 0001663588 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,771

Underlying: Common Stock · 2,771 shares

Expires 2035-06-09

F2 · derivative.exercise_date: The Stock option was granted on June 10, 2025 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001628280-25-030979 · wk-form4_1749759842.xml · nonDerivative · entry 1

Garrett Mary · CIK 0001663588 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,385

F1 · kind: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001628280-25-030971 · wk-form4_1749759670.xml · derivative · entry 2

Dodrill Amy M. · CIK 0001778116 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,771

Underlying: Common Stock · 2,771 shares

Expires 2035-06-09

F2 · derivative.exercise_date: The Stock option was granted on June 10, 2025 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001628280-25-030971 · wk-form4_1749759670.xml · nonDerivative · entry 1

Dodrill Amy M. · CIK 0001778116 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,626

F1 · kind: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001628280-25-029968 · wk-form4_1749240151.xml · derivative · entry 5

Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,578

Underlying: Common Stock · 20,000 shares

Expires 2030-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option is fully vested and exercisable.

SEC source: 0001628280-25-029968 · wk-form4_1749240151.xml · nonDerivative · entry 4

Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,133

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.29 to $65.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-029968 · wk-form4_1749240151.xml · nonDerivative · entry 3

Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,933

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.24 to $65.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-029968 · wk-form4_1749240151.xml · nonDerivative · entry 2

Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,837

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.24 to $64.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-029968 · wk-form4_1749240151.xml · nonDerivative · entry 1

Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,133

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 13

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 89,363

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024.

SEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 12

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 89,463

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.69 to $66.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 11

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 93,463

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.68 to $65.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 10

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 106,011

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.67 to $64.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 9

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 111,957

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.65 to $63.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-029800 · wk-form4_1749168189.xml · nonDerivative · entry 8

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 113,663

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.60 to $62.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.